首页> 美国卫生研究院文献>Pharmaceutics >Drug–Drug Interactions in Elderly Patients with Potentially Inappropriate Medications in Primary Care Nursing Home and Hospital Settings: A Systematic Review and a Preliminary Study
【2h】

Drug–Drug Interactions in Elderly Patients with Potentially Inappropriate Medications in Primary Care Nursing Home and Hospital Settings: A Systematic Review and a Preliminary Study

机译:老年患者的药物 - 药物相互作用初级保健护理家庭和医院环境潜在不适当的药物:系统审查和初步研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Drug–drug interactions (DDI) occurring with potentially inappropriate medications (PIM) are additional risk factors that may increase the inappropriate character of PIM. The aim of this study was (1) to describe the prevalence and severity of DDI in patients with PIM and (2) to evaluate the DDI specifically regarding PIM. This systematic review is based on a search carried out on PubMed and Web-of-Science from inception to June 30, 2020. We extracted data of original studies that assessed the prevalence of both DDI and PIM in elderly patients in primary care, nursing home and hospital settings. Four hundred and forty unique studies were identified: 91 were included in the qualitative analysis and 66 were included in the quantitative analysis. The prevalence of PIM in primary care, nursing home and hospital were 19.1% (95% confidence intervals (CI): 15.1–23.0%), 29.7% (95% CI: 27.8–31.6%) and 44.6% (95% CI: 28.3–60.9%), respectively. Clinically significant severe risk-rated DDI averaged 28.9% (95% CI: 17.2–40.6), in a hospital setting; and were approximately 7-to-9 lower in primary care and nursing home, respectively. Surprisingly, only four of these studies investigated DDI involving specifically PIM. Hence, given the high prevalence of severe DDI in patients with PIM, further investigations should be carried out on DDI involving specifically PIM which may increase their inappropriate character, and the risk of adverse drug reactions.
机译:药物 - 药物相互作用(DDI)发生潜在的药物(PIM)是额外的危险因素,可能增加PIM的不恰当性格。本研究的目的是(1)描述PIM和(2)患者DDI的患病率和严重程度,以评估专门关于PIM的DDI。该系统审查基于从成立于2020年6月30日开始的PubMed和科学网络进行的搜索。我们提取了原始研究数据,这些研究数据评估了DDI和PIM在初级保健中的老年患者中的DDI和PIM的普遍存在的数据和医院设置。鉴定了四百四十个独特的研究:91在定性分析中包含在定性分析中,并且在定量分析中包含66个。 PIM在初级保健,养老院和医院的PIM患病率为19.1%(95%置信区间(CI):15.1-23.0%),29.7%(95%CI:27.8-31.6%)和44.6%(95%CI:分别为28.3-60.9%。临床上严重的严重风险评级DDI平均为28.9%(95%CI:17.2-40.6),在医院环境中;分别在初级保健和养老院中大约7比9。令人惊讶的是,这些研究中只有四项调查了涉及专门PIM的DDI。因此,鉴于PIM患者的严重DDI的患病率高,应在涉及专门PIM的DDI上进行进一步调查,这可能增加其不恰当的性格,以及不良药物反应的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号